U.S. flag

An official website of the United States government

NM_020631.6(PLEKHG5):c.2113G>A (p.Glu705Lys) AND Inborn genetic diseases

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 15, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002417519.2

Allele description [Variation Report for NM_020631.6(PLEKHG5):c.2113G>A (p.Glu705Lys)]

NM_020631.6(PLEKHG5):c.2113G>A (p.Glu705Lys)

Gene:
PLEKHG5:pleckstrin homology and RhoGEF domain containing G5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.31
Genomic location:
Preferred name:
NM_020631.6(PLEKHG5):c.2113G>A (p.Glu705Lys)
HGVS:
  • NC_000001.11:g.6469178C>T
  • NG_007978.1:g.55832G>A
  • NG_029910.1:g.2018G>A
  • NM_001042663.3:c.2224G>A
  • NM_001042664.2:c.2113G>A
  • NM_001042665.2:c.2113G>A
  • NM_001265592.2:c.2224G>A
  • NM_001265593.2:c.2320G>A
  • NM_001265594.3:c.2113G>A
  • NM_020631.6:c.2113G>AMANE SELECT
  • NM_198681.4:c.2113G>A
  • NP_001036128.2:p.Glu742Lys
  • NP_001036129.1:p.Glu705Lys
  • NP_001036129.1:p.Glu705Lys
  • NP_001036130.1:p.Glu705Lys
  • NP_001036130.1:p.Glu705Lys
  • NP_001252521.2:p.Glu742Lys
  • NP_001252522.1:p.Glu774Lys
  • NP_001252522.1:p.Glu774Lys
  • NP_001252523.1:p.Glu705Lys
  • NP_001252523.1:p.Glu705Lys
  • NP_065682.2:p.Glu705Lys
  • NP_065682.2:p.Glu705Lys
  • NP_941374.3:p.Glu705Lys
  • LRG_262t1:c.2113G>A
  • LRG_262:g.55832G>A
  • LRG_262p1:p.Glu705Lys
  • NC_000001.10:g.6529238C>T
  • NM_001042664.1:c.2113G>A
  • NM_001042665.1:c.2113G>A
  • NM_001265593.1:c.2320G>A
  • NM_001265594.2:c.2113G>A
  • NM_020631.3:c.2113G>A
Protein change:
E705K
Molecular consequence:
  • NM_001042663.3:c.2224G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042664.2:c.2113G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042665.2:c.2113G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001265592.2:c.2224G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001265593.2:c.2320G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001265594.3:c.2113G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020631.6:c.2113G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198681.4:c.2113G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002726392Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)		Uncertain significance
(Oct 15, 2019) 		germlineclinical testing

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV002726392.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The p.E705K variant (also known as c.2113G>A), located in coding exon 18 of the PLEKHG5 gene, results from a G to A substitution at nucleotide position 2113. The glutamic acid at codon 705 is replaced by lysine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024